Beckman Coulter acquires Cytobank to provide standardized cytometric analysis

By Maggie Lynch

- Last updated on GMT

(Image: Getty/mikdam)
(Image: Getty/mikdam)

Related tags Beckman coulter Cytometry Life sciences Life sciences companies Data collection data analysis analytics

SaaS company Cytobank was acquired by Beckman Coulter Life Sciences to provide standardized cytometry data analytics to its clients.

The acquired software as a service (SaaS) company, Cytobank, will provide cloud and machine learning-based software for single-cell data analysis, sharing, and archiving to Beckman Coulter’s clients.

Cytobank’s platform provides accelerated research productivity through high-dimensional multi-omics data analysis, visualization, and collaboration across multiple sites, according to the company.

Beckman Coulter Life Sciences’ a California-based biomedical testing manufacturer will tie in the capabilities gained from this acquisition to its CytoFLEX LX 21-color flow cytometer for additional high-complexity workflow and data analysis for clinical research scientists.

David Craford, president and CEO of Cytobank, told us that the company’s platform will enable Beckman’s customers to use machine learning-based analysis to approach their cytometric data more objectively and share their analyses with clinical research collaborators.

Cytobank will join Beckman Coulter Life Sciences through the Danaher Life Sciences platform, which has generated approximately $6.5bn of revenue in 2018 through the combined work of Beckman Coulter, SCIEX, Molecular Devices, Pall, and Leica Microsystems.

Related news

Show more

Related products

show more

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Content provided by Elligo Health Research® | 13-Apr-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us

Products

View more

Webinars